NCT06522815 Updating Deep Learning Algorithms for OSA Monitoring
| NCT ID | NCT06522815 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sky Labs |
| Condition | Obstructive Sleep Apnea |
| Study Type | INTERVENTIONAL |
| Enrollment | 107 participants |
| Start Date | 2022-10-19 |
| Primary Completion | 2025-04-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 107 participants in total. It began in 2022-10-19 with a primary completion date of 2025-04-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective is to enhance the reliability of the algorithm to match that of Level 1 polysomnography by leveraging the diverse data obtained from Level 1 polysomnography to refine the deep learning algorithm.
Eligibility Criteria
Inclusion Criteria: Patients scheduled for Level 1 polysomnography at a sleep center who meet all of the following criteria: * Aged 19 years or older * Have listened to and understood a thorough explanation of the clinical study and voluntarily agreed to participate Exclusion Criteria: * Under 19 years of age * Unable to collect normal signals during the pre-test or wearing of the CART-I PLUS device * Refuse to participate in the clinical study * Have cognitive impairments to the extent that they cannot understand the explanation of the clinical study and therefore cannot make a voluntary decision to participate (e.g., legally incompetent individuals)
Contact & Investigator
Won Joo Kim, MD, PhD
PRINCIPAL INVESTIGATOR
Gangnam Severance Hospital
Frequently Asked Questions
Who can join the NCT06522815 clinical trial?
This trial is open to female participants only, aged 19 Years or older, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06522815 currently recruiting?
Yes, NCT06522815 is actively recruiting participants. Contact the research team at gerrard.kim@skylabs.io for enrollment information.
Where is the NCT06522815 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06522815 clinical trial?
NCT06522815 is sponsored by Sky Labs. The principal investigator is Won Joo Kim, MD, PhD at Gangnam Severance Hospital. The trial plans to enroll 107 participants.